- Details
- Description
Packaging Size:
30 tablets
Strength:
100 mg
Composition:
Lorlatinib
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
Lornatib 100
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Lornatib 100 (Lorlatinib) is an oral targeted anti-cancer medicine containing lorlatinib 100 mg, a kinase inhibitor designed to block abnormal signaling from ALK and ROS1 proteins involved in cancer growth. It is primarily used for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) and may help slow tumor growth and spread. Lornatib 100 is supplied as film-coated tablets in a pack of 30.
